EXSCIENTIA PLC (EXAI)

US30223G1022 - ADR

5.78  +0.04 (+0.7%)

Premarket: 5.8 +0.02 (+0.35%)

News Image
7 days ago - InvestorPlace

EXAI Stock Earnings: Exscientia Misses EPS, Misses Revenue for Q4 2023

EXAI stock results show that Exscientia missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

News Image
7 days ago - BusinessInsider

EXAI Stock Earnings: Exscientia Misses EPS, Misses Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Exscientia (NASDAQ:EXAI) just reported results for the fourth quarter of 2023.E...

News Image
16 days ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Exscientia plc - EXAI

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Exscientia plc ("Exscientia" or the "Company") (NASDAQ: EXAI). Such investors...

News Image
24 days ago - InvestorPlace

The Top 3 Healthcare Stocks to Buy on Weakness in 2024

Many healthcare stocks have extremely bright outlooks and very low valuations. Here are three top healthcare stocks to buy. 

News Image
24 days ago - Market News Video

EXAI Crosses Below Key Moving Average Level

News Image
25 days ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Exscientia plc - EXAI

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Exscientia plc ("Exscientia" or the "Company") (NASDAQ: EXAI). Such investors...

News Image
a month ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Exscientia plc - EXAI

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Exscientia plc ("Exscientia" or the "Company") (NASDAQ: EXAI). Such investors...

News Image
a month ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Exscientia plc - EXAI

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Exscientia plc ("Exscientia" or the "Company") (NASDAQ: EXAI). Such investors...

News Image
a month ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're starting the trading week with a breakdown of the biggest pre-market stock movers worth reading about for Monday morning!

News Image
3 months ago - InvestorPlace

M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024

Lower interest rates and the low valuation of many biotech stocks are likely to result in many drug maker stocks being acquired in 2024. 

News Image
3 months ago - Seeking Alpha

Absci stock gains as AI drug discovery rallies (NASDAQ:ABSI)

Absci Corporation (ABSI) reaches new highs as AI-led drug development gains momentum, fueled by deals with industry leaders like Nvidia (NVDA). Read more here.

News Image
4 months ago - The Motley Fool

Looking for the Next Big Thing? Add This AI Biotech to Your Watch List Right Now

Exscientia has the potential to be a star collaborator and a profitable drug developer, too.

News Image
5 months ago - InvestorPlace

3 Cutting-Edge Biotech Stocks for the Bold Investor

With broader market concerns rising, investors may want to consider the relatively insulated allure of biotech stocks to buy.